Histopathology of Skin Cancer

  • G. GoldenbergEmail author
  • L. E. Golitz
  • J. Fitzpatrick

Core Messages

  • The different histologic patterns of skin cancer are vital for the proper diagnosis and treatment of skin malignancies. This chapter reviews his-tologic findings of multiple skin malignancies, as well as their different histologic patterns. The use of immunohistochemical stains is also reviewed.


Basal Cell Carcinoma Merkel Cell Carcinoma Actinic Keratosis Desmoplastic Malignant Melanoma Lentigo Maligna 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    1. Röwert-Huber J, Patel MJ, Forschner T, Ulrich C, Eberle J, Kerl H, Sterry W, Stockfleth E (2007) Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclas-sification. Br J Dermatol 156(Suppl 3):8–12PubMedCrossRefGoogle Scholar
  2. 1.
    1. Kanitakis J, Euvrard S, Chouvet B et al (2006) Merkel cell carcinoma in organ-transplant recipients: report of two cases with unusual histological features and literature review. J Cutan Pathol 33:686–694PubMedCrossRefGoogle Scholar
  3. 2.
    2. Ratner D, Nelson BR, Brown MD, et al (1993) Merkel cell carcinoma. Journal of the American Academy of Dermatology 29(2 part 1):143–156PubMedCrossRefGoogle Scholar
  4. 1.
    Walsh JS, Perniciaro C, Randle HW (1999) Calcifying basal cell carcinomas. Dermatol Surg 25(1):49–51PubMedCrossRefGoogle Scholar
  5. 2.
    Crowson, AN (2006) Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol 19(Suppl 2):S127–S147PubMedCrossRefGoogle Scholar
  6. 3.
    Crowson AN, Magro CM, Kadin M et al (1996) Differential expression of bcl-2 oncogene in human basal cell carcinoma. Hum Pathol 27:355–359PubMedCrossRefGoogle Scholar
  7. 4.
    Jones CC, Ansari SJ, Tschen JA (1991) Cystic fibroepithe-lioma of Pinkus. J Cutan Pathol 18:220–222PubMedCrossRefGoogle Scholar
  8. 5.
    Spoonemore K, Crowson AN (2004) Eccrine syringofi-broadenoma in a patient with chronic graft-versus-host disease (Abstract). J Cutan Pathol 1:128–129Google Scholar
  9. 6.
    Latza U, Niedobitek G, Schwarting R, Nekarda H, Stein H (1990) Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. J Clin Pathol 43:213PubMedCrossRefGoogle Scholar
  10. 7.
    Tellechea O, Reis JP, Domingues JC, Baptista AP (1993) Monoclonal antibody Ber EP4 distinguishes basal-cell carcinoma from squamous-cell carcinoma of the skin. Am J Dermatopathol 15:452PubMedCrossRefGoogle Scholar
  11. 8.
    Jones MS, Helm KF, Maloney ME (1997) The immunohis-tochemical characteristics of the basosquamous cell carcinoma. Dermatol Surg 23:181PubMedCrossRefGoogle Scholar
  12. 9.
    Beer TW, Shepherd P, Theaker JM (2000) Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin. Histopathology 37:218PubMedCrossRefGoogle Scholar
  13. 10.
    Rossen K, Thomsen HK (2001) Ber-EP4 immunoreactivity depends on the germ layer origin and maturity of the squamous epithelium. Histopathology 39:386PubMedCrossRefGoogle Scholar
  14. 11.
    Krahl D, Sellheyer K (2007) Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma. J Cutan Pathol Oct; 34(10):782–787CrossRefGoogle Scholar
  15. 12.
    Ackerman AB (1980) Malignant melanoma: a unifying concept. Hum Pathol 11(6):591–595PubMedCrossRefGoogle Scholar
  16. 13.
    Elder DE (2006) Pathology of melanoma. Clin Cancer Res 12(7 Pt 2):2308s–2311sPubMedCrossRefGoogle Scholar
  17. 14.
    Clark WH et al (1989) Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 81(24):1893–1904PubMedCrossRefGoogle Scholar
  18. 15.
    Weyers W, Bonczkowitz M, Weyers I, Bittinger A, Schill WB (1996) Melanoma in situ versus melanocytic hyperpla-sia in sun-damaged skin. Assessment of the significance of histopathologic criteria for differential diagnosis. Am J Dermatopathol Dec;18(6):560–566CrossRefGoogle Scholar
  19. 16.
    Flotte TJ, Mihm MC Jr (1999) Lentigo maligna and malignant melanoma in situ, lentigo maligna type. Hum Pathol 30(5):533–536PubMedCrossRefGoogle Scholar
  20. 17.
    Kuchelmeister C, Schaumburg-Lever G, Garbe C (2000) Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients. Br J Dermatol Aug 143(2):275–280CrossRefGoogle Scholar
  21. 18.
    Thelmo MC, Sagebiel RW, Treseler PA, Morita ET, Nguyen LH, Kashani-Sabet M, Leong SP (2001) Evaluation of sentinel lymph node status in spindle cell melanomas. J Am Acad Dermatol 44(3):451–455PubMedCrossRefGoogle Scholar
  22. 19.
    Carlson JA, Dickersin GR, Sober AJ, Barnhill RL (1995) Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases. Cancer 75(2):478–494PubMedCrossRefGoogle Scholar
  23. 20.
    Leu HJ, Odermatt B (1985) Multicentric angiosarcoma (Kaposi's sarcoma). Light and electron microscopic and immu-nohistological findings of idiopathic cases in Europe and Africa and of cases associated with AIDS are histologically identical. Virchows Arch A Pathol Anat Histopathol 408(1):29–41PubMedCrossRefGoogle Scholar
  24. 21.
    Chow JW, Lucas SB (1990) Endemic and atypical Kaposi's sarcoma in Africa –histopathological aspects. Clin Exp Dermatol 15(4):253–259PubMedCrossRefGoogle Scholar
  25. 22.
    Cottoni F, Montesu MA (1996) Kaposi's sarcoma classification: a problem not yet defined. Int J Dermatol 35(7):480–483PubMedCrossRefGoogle Scholar
  26. 23.
    Olsen SJ, Moore PS (1998) Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) and the etiology of KS. In: Medveczky P, Friedman H, Bendinelli M (eds) Herpesviruses and immunity. Plenum, New YorkGoogle Scholar
  27. 24.
    Robin YM et al (2004) Human herpesvirus 8 immunostain-ing: a sensitive and specific method for diagnosing Kaposi sarcoma in paraffin-embedded sections. Am J Clin Pathol 121:330–334PubMedCrossRefGoogle Scholar
  28. 25.
    Shimizu A, O'Brien KP, Sjöblom T et al (1999) The der-matofibrosarcoma protuberans-associated collagen type I1/ platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB. Cancer Res 59:3719–3723PubMedGoogle Scholar
  29. 26.
    Weiss SW, JR Goldblum (2001) Fibrohistiocytic tumors of intermediate malignancy. In: SW Weiss, JR Goldblum (eds) Enzinger and Weiss's soft tissue tumors, 4th edn. Mosby, St Louis, pp 491–534Google Scholar
  30. 27.
    Weiss SW, Nickoloff BJ (1993) CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol 17:1039–1045PubMedCrossRefGoogle Scholar
  31. 28.
    Terrier-Lacombe MJ, Guillou L, Maire G, Terrier P, Vince DR, de Saint Aubain Somerhausen N, Collin F, Pedeutour F, Coindre JM (2003) Dermatofibrosarcoma pro-tuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data — a study from the French Federation of Cancer Centers Sarcoma Group. Am J Surg Pathol 27(1):27–39PubMedCrossRefGoogle Scholar
  32. 29.
    Kanitakis J, Bourchany D, Claudy A (2000) Expression of the CD10 antigen (neutral endopeptidase) by mesenchymal tumors of the skin. Anticancer Res 20(5B):3539–3544PubMedGoogle Scholar
  33. 30.
    Dettrick A, Geoff S (2006) Atypical fibroxanthoma with perineural or intraneural invasion: report of two cases. J Cutan Pathol 33:318–322PubMedCrossRefGoogle Scholar
  34. 31.
    Weedon D, Williamson R, Mirza B (2005) CD10, a useful marker for atypical fibroxanthomas. Am J Dermatopathol 27(2):181PubMedCrossRefGoogle Scholar
  35. 32.
    Jensen K, Wilkinson B, Wines N, Kossard S (2004) Procollagen 1 expression in atypical fibroxanthoma and other tumors. J Cutan Pathol 31(1):57–61PubMedCrossRefGoogle Scholar
  36. 33.
    Fletcher CD (2006) The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology 48(1):3–12PubMedCrossRefGoogle Scholar
  37. 34.
    Derré J, Lagace R, Nicolas A et al (2001) Leiomyosarcomas and most malignant fibrous histiocytomas share very similar comparative genomic hybridization imbalances: an analysis of a series of 27 leiomyosarcomas. Lab Invest 81:211–215PubMedCrossRefGoogle Scholar
  38. 35.
    Chibon F, Mariani O, Mairal A et al (2003) The use of clustering software for the classification of comparative genomic hybridization data. An analysis of 109 malignant fibrous histiocytomas. Cancer Genet Cytogenet 141:75–78PubMedCrossRefGoogle Scholar
  39. 36.
    Iwasaki H, Isayama T, Johzaki H, Kikuchi M (1987) Malignant fibrous histiocytoma. Evidence of perivascular mesenchymal cell origin immunocytochemical studies with monoclonal anti-MFH antibodies. Am J Pathol 128(3):528–537Google Scholar
  40. 37.
    Lazova R, Moynes R, May D, Scott G (1997) LN-2 (CD74) A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma. Cancer 79(11):2115–2124PubMedCrossRefGoogle Scholar
  41. 38.
    Smith ME, Costa MJ, Weiss SW (1991) Evaluation of CD68 and other histiocytic antigens in angiomatoid malignant fibrous histiocytoma. Am J Surg Pathol 15(8):757–763PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  1. 1.Medical Director of the Dermatology Faculty PracticeMt Sinai School of MedicineNY

Personalised recommendations